In p53-wildtype colon cancer xenografts, MTF treatment did not affect tumor growth but initiated autophagy, whereas in p53-deficient colon cancer xenografts, MTF selectively inhibited tumor growth and induced apoptosis. Here, TP53 is linked to malignant colon neoplasm.